Latest Capital Funding News

Latitude 66 has finalised the sale of its non-core Piastri Project to Capricorn Metals, converting the deal into approximately A$1.79 million in shares. Alongside a recent royalty portfolio sale, this boosts Latitude 66’s war chest with over A$5 million to fund core exploration in Finland and Western Australia.

Impact Minerals (ASX:IPT) has initiated a renounceable pro-rata entitlement offer to raise up to $4.13 million at $0.032 per share, with two free attaching options for every three new shares. The partially underwritten raise aims to fund exploration and development across its key projects including High Purity Alumina.

Lake Resources has completed a A$1.1 million at-the-market equity raise at a 7.6% discount, directing funds towards advancing environmental and power optimisation efforts at its Kachi lithium project.

PM Capital Global Opportunities Fund Limited delivered a 41.5% jump in profit after tax to $238 million for FY26 and raised its fully franked dividend guidance to 16 cents for FY27, reflecting strong portfolio returns and robust earnings reserves.

Percheron Therapeutics announces Dr Michael Baker as incoming CEO, replacing Dr James Garner who steps down after three years. Baker’s appointment aligns executive incentives with shareholder value as the company prepares for a pivotal HMBD-002 clinical trial.

Theta Gold Mines has locked in a US$90 million senior secured bond and raised US$18.6 million in equity, pushing its TGME Gold Project construction steadily towards first gold in early 2027.

Critical Minerals Group’s Pre-Feasibility Study for its Lindfield Vanadium Project delivers a robust $821 million pre-tax NPV and 26.6% IRR, setting the stage for a Definitive Feasibility Study and potential final investment decision in 2027.

Odyssey Gold’s Stage 1 Scoping Study for the Tuckanarra Project outlines a low-capital, high-margin open-pit mining operation producing 79,000 ounces of gold over 29 months with pre-tax cashflows of A$180 million at A$6,000/oz gold price.

Anson Resources has secured backing from three Utah congressional representatives for its $85 million Department of Energy grant bids, targeting development of its Green River Lithium Project in Utah.

Nexalis Therapeutics has ended funding negotiations with Point8 Capital after failing to secure a formal agreement, while successfully completing its IRX-616a Phase 1 trial with no serious adverse events. The company is reassessing clinical priorities amid funding uncertainty.

AuMEGA Metals appoints Rafael Gradim as President, replacing Michael Skead, to spearhead exploration across its significant Newfoundland gold portfolio.

Clime Investment Management has wrapped up major strategic initiatives including fund sales and business consolidations, while its flagship Clime Capital fund outperformed benchmarks. The company declared a fully franked interim dividend of 0.3 cents per share.